Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00797615 · ClinicalTrials.gov registry record · NA
Project Diabetes: Weight Gain Prevention in Hispanic Girls (GEMAS Study)
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT00797615 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 132 participants.
The verdict
NCT00797615, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
Over the past 30 years obesity has reached epidemic proportions in the United States (Ogden et al, 2006). While this epidemic affects all socioeconomic levels, certain racial/ethnic groups such as Hispanics, are disproportionately affected by obesity and diabetes. The age of onset of excess obesity in Hispanic females, formerly young adulthood, is now younger. Childhood obesity poses intermediate and long-term health risks, including: type 2 diabetes, hyperlipidemia, elevated blood pressure, and metabolic syndrome. Although biological factors may influence a child's risk for becoming overweight, the home environment has been shown to be a predisposing and reinforcing contextual factor for unhealthy eating and exercise behaviors. Since parents are the primary transmitters of Hispanic cultural practices and significantly influence their children's diet and physical activity behaviors from preschool through high school, family-based weight-gain prevention interventions are likely to be effective. The goal of this implementation study is to contribute to the reduction of racial/ethnic disparities in obesity and risk of type 2 diabetes by tailoring a recently successful childhood obesity prevention program originally developed for African American girls to implement and evaluate with preadolescent Hispanic girls.
Interventions
- BEHAVIORAL Active intervention
- BEHAVIORAL Alternative Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00797615
The ClinicalTrials.gov registry entry for NCT00797615 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active intervention is the first listed.
NCT00797615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00797615 about?
NCT00797615 is a clinical study titled "Project Diabetes: Weight Gain Prevention in Hispanic Girls (GEMAS Study)". Over the past 30 years obesity has reached epidemic proportions in the United States (Ogden et al, 2006). While this epidemic affects all socioeconomic levels, certain racial/ethnic groups such as Hispanics, are disproportionately affected by obesity and diabetes. The age of onset of excess obesity ...
What is the current status of trial NCT00797615?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2008-11. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00797615?
The interventions under investigation include: Active intervention (BEHAVIORAL), Alternative Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00797615?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.